PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Indo Us Bio-Tech Limited

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (5)

Compared with Basic Materials companies in India.

P/E ratio

11.2

Investors pay ₹11.2 for every ₹1 of Indo Us Bio-Tech Limited's yearly profit, lower than 80% of Basic Materials companies in India.

P/B ratio

1.38

The share price is 1.38 times Indo Us Bio-Tech Limited's book value per share, lower than 61% of Basic Materials companies in India.

Market cap

₹128 Cr

The total market value of all of Indo Us Bio-Tech Limited's shares at today's price (share price × number of shares), smaller than 91% of Basic Materials companies in India. PosiCap size class: Micro Cap.

Return on equity (ROE)

12.4%

Indo Us Bio-Tech Limited earned 12.4% on its shareholders' money over the last year, higher than 61% of Basic Materials companies in India.

Dividend yield

None

Indo Us Bio-Tech Limited does not currently pay a dividend.

Questions

What is Indo Us Bio-Tech Limited's P/E ratio?

Investors pay ₹11.2 for every ₹1 of Indo Us Bio-Tech Limited's yearly profit, lower than 80% of Basic Materials companies in India.

What is Indo Us Bio-Tech Limited's return on equity?

Indo Us Bio-Tech Limited earned 12.4% on its shareholders' money over the last year, higher than 61% of Basic Materials companies in India.

Does Indo Us Bio-Tech Limited pay a dividend?

No. Indo Us Bio-Tech Limited does not currently pay a dividend.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.